Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a strategic move to consolidate its leadership in the rapidly expanding obesity drug market, Novo Nordisk announced a landmark...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a bold move to secure leadership in the rapidly evolving hepatology sector, GSK announced a $2 billion acquisition of Boston...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand Deal at a Glance ⚖️ Valuation: $10B+ enterprise value 📈 Key Growth Driver: 78% CAGR in GLP-1 drug packaging since 2022 🩺...
HistoSonics, the Johnson & Johnson-backed pioneer of histotripsy technology, stands at the center of a high-stakes acquisition battle that could redefine tumor treatment paradigms. With Medtronic,...